Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Satoyoshi syndrome is likely an autoimmune disease.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

Women with severe frontal fibrosing alopecia are more likely to have rosacea.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

Early diagnosis and treatment are crucial for managing Folliculotropic Mycosis Fungoides on the scalp.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

The document suggests a possible link between FAM111B gene mutations and increased cancer risk, particularly pancreatic cancer.

A 54-year-old man with painful skin blisters and fever was diagnosed with Sweet syndrome and successfully treated with corticosteroids.

Cyclosporine effectively treated a woman's stubborn skin condition.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Managing multiple autoimmune diseases in one patient is very challenging.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Avoiding salicylates improved skin issues and stabilized hair loss in a woman with frontal fibrosing alopecia.

Fahr syndrome causes brain calcification and is managed by treating symptoms and underlying issues.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Early diagnosis and treatment can prevent or delay frontal fibrosing alopecia progression in postmenopausal women.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

The study found that a specific type of hair loss is increasingly common in premenopausal women and can be effectively diagnosed and treated with various medications.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.